Scientists Discovered Why Some Brain Cells Survive Alzheimer’s While Others Don’t

Alzheimer’s disease does not destroy all brain cells equally. Some neurons accumulate toxic tau proteins and die. Others, sitting in the same brain, exposed to the same disease environment, survive. Scientists have long known this pattern exists, but could not explain why. A new study from UCLA Health and UC San Francisco has now answered that question, and the answer points directly toward new treatment strategies. Researchers identified a natural cellular cleanup system that helps certain neurons remove tau before it can form the harmful clumps that drive neurodegeneration. They also found an unexpected link between cellular energy failure and one of the most dangerous forms of tau found in Alzheimer’s patients.

What Tau Does to the Brain, and Why It Matters

Tau is a protein that normally plays a supporting role in brain health. In its functional state, it helps stabilize the internal structures of neurons and supports the transport of nutrients through nerve cells. When tau misfolds and clumps together, however, it becomes one of the most destructive agents in neurodegenerative disease.

Tau aggregation is the defining feature of a broad category of brain diseases called tauopathies, which includes Alzheimer’s disease, frontotemporal dementia, and several other conditions. As tau clumps build up inside neurons, they damage cellular machinery, disrupt communication between nerve cells, and eventually cause neurons to die. Tau is the most common protein known to aggregate in neurodegenerative disorders, and the degree of tau clumping correlates with how far the disease has progressed.

What has puzzled researchers for years is why this process affects some neurons far more than others. In the same brain, with the same tau mutation, some neurons accumulate toxic clumps and die while neighboring cells remain functional. Identifying what makes certain neurons resistant to that damage is one of the most pressing questions in Alzheimer’s research.

A CRISPR Screen Across Nearly Every Gene in the Human Genome

To find an answer, researchers at UCLA Health and UC San Francisco designed one of the most expansive genetic investigations of tau regulation ever conducted. Rather than targeting a handful of suspect genes, they used a CRISPR-based gene silencing tool called CRISPRi to systematically switch off individual genes, one at a time, across nearly the entire human genome.

Human neurons grown in the lab from stem cells served as the experimental model. Crucially, these neurons carried a real disease-causing mutation called MAPT V337M, which causes tau proteins to adopt a particularly harmful shape known as the Alzheimer fold. Using cells with an actual disease mutation rather than a simulated model gave researchers confidence that what they found would be relevant to human disease.

First author Dr. Avi Samelson, assistant professor of Neurology at UCLA Health, who researched while at UCSF, described the scope of the work. His team wanted to understand why some neurons are vulnerable to tau accumulation while others are more resilient. By systematically screening nearly every gene in the human genome, they found both expected pathways and completely unexpected ones that control tau levels in neurons.

Out of more than 20,000 genes tested, more than 1,000 came back as influencing how toxic tau builds up inside neurons. From that large pool, one protein complex stood out as a primary regulator of tau clearance.

Meet the Brain’s Tau Cleanup System

At the center of the findings is a protein complex called CRL5SOCS4. Researchers identified it as a key component of the brain’s natural defense against tau accumulation. CRL5SOCS4 functions by attaching molecular tags to tau proteins, a process that marks them for destruction by the cell’s protein recycling machinery, known as the proteasome.

Senior author Martin Kampmann, professor of biochemistry and biophysics at UCSF, called it the first time researchers have been able to screen human neurons for genes that determine their resilience to tau. CRL5SOCS4 acts like a molecular hazmat team, flagging toxic tau before it can aggregate and routing it toward disposal.

To confirm that laboratory findings matched what happens in actual Alzheimer’s disease, the team consulted the Seattle Alzheimer’s Disease Brain Atlas, a detailed database compiled from brain tissue of deceased Alzheimer’s patients. When they examined that real-world data, the pattern held. Neurons with higher levels of CRL5SOCS4 components showed greater survival rates in the presence of tau accumulation. Brain cells better equipped with this cleanup complex lasted longer against the disease.

Mitochondria Failure Creates a Dangerous Tau Fragment

Beyond CRL5SOCS4, the study uncovered a second and unexpected mechanism linking cellular energy failure to tau toxicity. Mitochondria, the structures that generate energy inside cells, play a larger role in Alzheimer’s pathology than previously understood.

When researchers disrupted genes that control mitochondrial function, cells began producing a specific tau fragment roughly 25 kilodaltons in size. Researchers recognized this fragment. It closely matches NTA-tau, a biomarker detected in the blood and cerebrospinal fluid of Alzheimer’s patients and one of the more accurate indicators of disease activity currently available.

Samelson explained the mechanism. Oxidative stress, which is common in aging and neurodegeneration and rises when mitochondria malfunction, reduces the efficiency of the proteasome. When the proteasome cannot work properly, it processes tau incorrectly, generating this harmful fragment rather than fully breaking it down. That fragment changes how tau proteins cluster together, making tau stickier and more likely to form the kinds of aggregates that damage neurons.

In simple terms, when a cell’s energy production starts to break down, its waste disposal system weakens, and that weakening produces a form of tau more prone to causing the damage associated with Alzheimer’s disease.

What These Findings Could Mean for Treatment

Two potential therapeutic directions emerge from this research. Each targets a different part of the tau processing chain that researchers mapped.

The first involves boosting CRL5SOCS4 activity. If researchers can identify small molecules that strengthen the interaction between CRL5SOCS4 and tau, they could help neurons tag more tau for destruction before it reaches the aggregation stage. Neurons already performing this clearance function survive longer, so amplifying that capacity in more vulnerable cells could slow or prevent damage.

The second direction involves protecting the proteasome during periods of cellular stress. If the proteasome’s efficiency can be maintained even under oxidative stress, the chain of events that produces harmful tau fragments could be interrupted before it starts. Preserving protein recycling capacity may be as important as targeting tau directly.

Kampmann framed the broader opportunity concisely. A future therapy could enhance the body’s natural mechanism for avoiding neurodegeneration. Rather than introducing foreign agents or attempting to override the brain’s biology, these approaches would work by strengthening defenses that evolution has already built into neurons.

New Pathways Researchers Did Not Expect to Find

Beyond CRL5SOCS4 and the mitochondria-proteasome connection, the large-scale genetic screen identified additional biological pathways not previously associated with tau regulation.

One involves a protein modification process called UFMylation. Another involves enzymes responsible for building molecular anchors within cell membranes. Neither pathway had a recognized role in tau processing before this study, and researchers do not yet fully understand how they function in that context.

Their discovery suggests that tau regulation inside neurons is more complex than current models describe, and that additional protective mechanisms, some still entirely uncharacterized, may be waiting to be found in the genome data the team has already generated. Each newly identified pathway represents a potential therapeutic target that prior research had no way of reaching.

The study was funded by the Rainwater Charitable Foundation, the Tau Consortium, and the National Institutes of Health. Researchers caution that translating these findings into treatments requires further work, but the genetic roadmap they have produced gives the field a clearer set of targets than it has ever had before.

Why This Changes How Alzheimer’s Research Should Think About Neurons

For decades, Alzheimer’s research has focused heavily on what goes wrong. Amyloid plaques form. Tau aggregates. Neurons die. Inflammation spreads. Treatments built on that model have tried to clear plaques or slow tau spread, with mixed results.

What this study adds is a detailed look at what goes right in neurons that survive. Rather than asking only what kills neurons, researchers asked what protects them. That shift in framing revealed an entire cleanup system that functions in healthy neurons and breaks down in vulnerable ones, and identified the specific molecular machinery responsible.

Understanding why certain neurons resist Alzheimer’s damage does not just explain the disease. It identifies the biological systems worth strengthening. A neuron that can efficiently tag tau for disposal, maintain mitochondrial function, and protect its proteasome from oxidative stress is a neuron that survives. Building therapies around those capacities may prove more effective than approaches aimed only at clearing damage after it has already occurred.

My Personal RX on Protecting Your Brain From Alzheimer’s at the Cellular Level

As a doctor and health advocate, what excites me most about this research is what it tells us about the brain’s own capacity to fight back. Your neurons already carry the biological tools to clear toxic tau and resist neurodegeneration. What determines whether those tools work well or break down comes down to the health of your cells, your mitochondria, and your brain’s overall inflammatory environment. That is something you have real influence over, starting today. Alzheimer’s does not arrive without warning. It builds over decades in cells under chronic stress, with mitochondria struggling to produce energy and proteasomes too burdened to clear damaged proteins. Every habit that reduces oxidative stress, supports mitochondrial health, and lowers inflammation is a habit that helps your neurons do exactly what this research describes. Protect the cleanup crew, and the cleanup crew protects you.

1. Support Mitochondrial Health Through Aerobic Exercise: Mitochondrial function declines with age and inactivity. Regular aerobic exercise, three to five days per week, stimulates mitochondrial biogenesis and reduces the oxidative stress that this study linked to harmful tau fragment production. Walking, cycling, and swimming all count.
2. Eat to Reduce Oxidative Stress: Foods rich in polyphenols, including blueberries, dark leafy greens, green tea, and extra virgin olive oil, neutralize the free radicals that trigger mitochondrial stress and impair proteasome function. A diet built around these foods directly supports the cellular defense system this research identified.
3. Prioritize Sleep for Proteasome Recovery: Proteasome activity, the same cellular recycling machinery that clears tau, peaks during deep sleep. Chronic sleep deprivation impairs protein clearance and allows damaged proteins to accumulate. Sleep Max combines magnesium, GABA, 5-HTP, and taurine to support restorative deep sleep so your brain’s protein recycling systems can run their nightly maintenance cycle.
4. Fill the Nutritional Gaps That Hurt Brain Cells: Deficiencies in vitamin D, B12, omega-3 fatty acids, and magnesium all increase oxidative stress and impair mitochondrial efficiency in neurons. Download The 7 Supplements You Can’t Live Without, a free guide covering the nutrients that matter most for brain protection and energy after 40, along with how to identify quality supplements from poor ones.
5. Manage Blood Sugar to Protect Neurons: Insulin resistance promotes mitochondrial dysfunction and oxidative stress in brain cells, two of the exact mechanisms this study linked to harmful tau processing. A low-glycemic diet, regular exercise, and adequate sleep all support stable blood sugar and healthier neurons.
6. Cut Chronic Stress to Protect Your Proteasome: Sustained psychological stress raises cortisol and inflammatory cytokines that impair proteasome function. Daily stress reduction practices, including breathwork, meditation, or time outdoors, reduce the oxidative burden that this research showed triggers dangerous tau fragmentation.
7. Stay Mentally Active: Cognitive engagement supports synaptic plasticity and may help neurons maintain the gene expression patterns associated with resilience in this study. Learning new skills, reading, solving problems, and maintaining social connections all support the biological environment in which tau clearance systems work best.
8. Know Your Genetic Risk and Monitor Early Biomarkers: If you have a family history of Alzheimer’s or carry known risk factors, speak with your doctor about early biomarker testing, including NTA-tau levels in blood. Catching signs of tau dysregulation early, before symptoms appear, opens the widest window for protective intervention.

Source: Samelson, A. J., Ariqat, N., McKetney, J., Rohanitazangi, G., Bravo, C. P., Bose, R. S., Travaglini, K. J., Lam, V. L., Goodness, D., Ta, T., Dixon, G., Marzette, E., Jin, J., Tian, R., Tse, E., Abskharon, R., Pan, H. S., Carroll, E. C., Lawrence, R. E., . . . Kampmann, M. (2026). CRISPR screens in iPSC-derived neurons reveal principles of tau proteostasis. Cell, 189(5), 1517-1534.e19. https://doi.org/10.1016/j.cell.2025.12.038